Volume 12, Number 5, 239-241, DOI: 10.1007/BF00256147

Importance of serum amyloid A (SAA) level in monitoring disease activity and response to therapy in patients with prostate cancer

J. Kaneti, Y. Winikoff, S. Zimlichman and R. Shainkin-Kestenbaum

View Related Documents

Abstract

Serum amyloid A (SAA) and acid phosphatase (AcP) levels were determined in serial serum samples of 35 patients in different stages of dissemination and correlated with activity of carcinoma of the prostate. Up to 500-fold increases in SAA level were detected during active periods of cancer with a decrease towards the normal range in remission, in comparison with a 10-fold increase of AcP. The correlation between these two parameters was highly significant (P<0.001), but="" while="" saa="" shows="" 100%="" sensivity="" during="" the="" active="" stage,="" acp="" shows="" only="" 85%="" sensitivity.="" it="" is="" suggested="" that="" althouth="" saa="" is="" not="" a="" specific="" marker="" for="" any="" particular="" illness,="" due="" to="" its="" characteristic="" pattern="" of="" change="" in="" malignant="" diseases="" and="" its="" high="" sensitivity,="" it="" represents="" a="" useful="" biochemical="" parameter="" for="" the="" assessment="" of="" the="" activity="" of="" the="" disease="" to="" monitor="" response="" to="" therapy="" during="">

Key words  Prostate cancer - Serum amyloid A (SAA) - Acid phosphatase (AcP)

The work was supported by a grant from the Israel Academy of Science-Basic Research

Fulltext Preview

Image of the first page of the fulltext document